NASDAQ: SRDX - Surmodics, Inc.

Yield per half year: -8.37%
Sector: Healthcare

Surmodics, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
322.17 48.72 561.23% 173.6 +85.58%
P/S 4.39 33.75 -86.99%
P/BV 4.66 4.82 -3.34%
P/FCF -166.06 61 -372.23%
Ev/Ebitda 463.63 -22.17 -2191.09%
Ev/S 4.37 22.56 -80.63%
Ev/FCF -169.79 68.75 -346.97%
E/P -0.0214 0.0178 -220.4%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
1/10
0.9423 4.98 -81.07% 2.44 -61.35%
ROE -9.67 9.61 -200.57%
ROA -6.34 0.3443 -1940.65%
ROIC -6.82 7.63 -189.33%
ROS -9.15 -25.17 -63.65%
ROCE -4.75 15.35 -130.94%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
0/10
27.98 -3.68 -861.25% 11.53 +142.75%
Nеt Debt/Ebitda -2.42 -3.44 -29.63%
Debt/Ratio 0.1862 0.1985 -6.21%
Debt/Equity 1.23 1.66 -26.21%
Debt/Net Income -2.88 10.32 -127.9%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5473 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 1.07 -100%
Average percentage for 5 years 0 0.498 -100%
Average percentage for payments 85.86 43.56 97.08%
Difference from average difference in sector -0.5473

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
32.85 -56.89 -157.74%
Growth impulse Ebitda in 5 years 22.85 -54.68 -141.79%
Growth impulse Net Income in 5 years -1149.27 -58.33 1870.29%
Growth impulse FCF in 5 years -131.5 -49.48 165.76%
Growth impulse EPS in 5 years -1103.09 -32.41 3303.55%
IP Score
2.72/10

Similar companies

Illumina

Nektar Therapeutics

Amarin

ImmunoGen

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription